ITPR3 and Charcot-Marie-Tooth disease: Additional studies, ideally in neuronal or animal models, will be needed to elucidate the effects of the disease variants on IP3R3 function and evaluate the potential of targeting Ca2+ flux as a therapeutic target in CMT.